Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
FEBS Letters|May 6, 1991
Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptaseD M Lowe, V Parmar, S D Kemp, et al.Science (New York, N.Y.)|December 1, 1989
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)B A Larder, S D KempAIDS (London, England)|February 1, 1991
Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytesB A Larder, P Kellam, S D KempThe EMBO Journal|January 1, 1987
Related functional domains in virus DNA polymerasesB A Larder, S D Kemp, G DarbyNature|September 30, 1993
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitroB A Larder, P Kellam, S D KempProceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivityB A Larder, S D Kemp, D J PurifoyScience (New York, N.Y.)|August 4, 1995
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapyB A Larder, S D Kemp, P R HarriganJournal of Virology|October 1, 1991
Zidovudine-resistant human immunodeficiency virus selected by passage in cell cultureB A Larder, K E Coates, S D KempProceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptaseM Tisdale, S D Kemp, N R Parry, et al.Nature|October 14, 1993
Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencingB A Larder, A Kohli, P Kellam, et al.Pageof 19